Tilray Brands, Inc. (TLRY)
Tilray stock price soars as we predicted: now what?
The Tilray stock price has risen in the past few days, a trend that accelerated this week. It jumped to a high of $8, up by over 30% from its lowest level this year.
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Tilray stock shows early reversal signals as U.S. cannabis rescheduling momentum builds, with a breakout and technical strength pointing toward a potential recovery continuation.
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report
Shares of cannabis giant Tilray Brands Inc (NASDAQ:TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift. Here's what investors need to know.
1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?
Roth Capital's Bill Kirk predicts that Tilray's shares could soar by more than 40% over the next 12 months. His bullish outlook stems from three encouraging signs with Tilray's business.
Here's why the Tilray Brands stock may surge soon despite major risks
Tilray Brands stock price has moved sideways in the past few weeks as momentum in the cannabis industry waned. It was trading at $6.90, down by over 70% from its highest level last year.
Tilray Brands Is Looking Better
Tilray Brands (TLRY) remains a Hold, with valuation near tangible book value and a mixed Q3 showing revenue growth but margin pressure. Strength in cannabis and distribution segments offset weak beverage sales, while international cannabis revenue soared 73% in Q3, now 37% of segment revenue. Adjusted EBITDA guidance for FY26 is $62–$72 million, with consensus FY28 margin expectations at 9.5%, but cash flow remains negative and M&A execution is a risk.
Tilray Brands' strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy' rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to improving fundamentals and increased visibility into the company's medium-term outlook. The brokerage reiterated a price target of $24, implying substantial upside if execution continues as expected.
Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?
TLRY posts mixed Q3 with revenue growth and narrowing losses, as strong cannabis and distribution gains offset beverage weakness and rising competition.
Tilray Brands, Inc. (TLRY) Q3 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q3 2026 Earnings Call Transcript
Deep dive: why Tilray stock sell-off despite record revenue makes sense
Tilray Brands (NASDAQ: TLRY) is seeing pressure this morning even after reporting an 11% year on year increase in revenue to a record $207 million for its third financial quarter. The price action may be puzzling to some, given the release signalled improving profitability and strong international cannabis growth as well.
Tilray Sinks 4%: 3 Reasons the Market Isn't Impressed Despite Record Q3 Revenue
Tilray Brands (NASDAQ:TLRY) shares declined 4% in Wednesday morning trading, falling to around $6.20 after opening at $6.47.
